Sensei Biotherapeutics Inc. (NASDAQ: SNSE)
$0.70
-0.0175 ( -2.44% ) 40.9K
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
Market Data
Open
$0.70
Previous close
$0.72
Volume
40.9K
Market cap
$18.06M
Day range
$0.70 - $0.74
52 week range
$0.51 - $1.94
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Mar 05, 2024 |
10-k | Annual reports | 98 | Feb 29, 2024 |
8-k | 8K-related | 16 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
8-k | 8K-related | 15 | Feb 08, 2024 |
8-k | 8K-related | 56 | Jan 04, 2024 |
10-q | Quarterly Reports | 74 | Nov 07, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |